IntrinsicIntrinsic
← Scroll for more →

Financial Statements — AEMD

Balance Sheet

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021
Cash & Equivalents4.935.036.965.853.775.504.836.869.075.447.9710.1814.5317.5012.9017.1620.4819.609.8612.13
Accounts Receivable------------------------0.000.000.110.130.130.110.150.11
Total Current Assets5.615.577.146.254.055.954.977.149.556.238.2510.4915.0918.1713.3118.1621.2120.5010.3512.32
Property, Plant & Equipment0.290.360.430.510.590.680.760.840.931.021.111.201.141.211.280.440.251.140.160.17
Intangible Assets--0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.060.06
Total Non-current Assets*0.620.760.921.071.261.411.561.711.862.022.192.342.422.552.491.260.712.540.320.35
Total Assets6.246.338.067.325.317.366.538.8511.428.2510.4412.8317.5120.7215.8019.4221.9223.0510.6712.67
Accounts Payable0.410.380.470.570.570.530.610.921.070.780.690.680.430.230.840.500.230.360.340.18
Total Current Liabilities1.041.451.261.401.631.901.772.332.131.832.101.711.512.441.821.821.072.101.381.24
Total Non-current Liabilities*0.000.000.090.170.260.340.420.500.570.650.720.800.941.010.870.600.291.080.000.00
Total Liabilities*1.041.451.341.581.882.242.192.832.702.482.832.512.443.452.692.431.363.181.381.24
Retained Earnings(176.65)(175.11)(173.22)(171.20)(169.72)(167.95)(161.70)(159.95)(157.14)(154.57)(152.14)(148.68)(142.36)(139.89)(145.64)(130.33)(126.54)(137.04)(119.91)(117.65)
Total Stockholder Equity5.204.896.715.753.425.124.336.028.715.777.6110.3215.0617.2813.1117.1320.7019.879.4311.57
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021
Total Revenue------------------------0.570.000.000.010.020.000.030.62
Research & Development0.550.560.530.290.521.300.240.260.410.640.590.630.620.560.680.940.350.850.720.46
Selling, General & Admin0.660.700.740.520.740.720.820.960.750.760.980.850.831.071.311.031.111.550.570.92
Total Operating Expenses1.581.932.061.511.792.001.812.902.622.493.573.183.052.853.413.802.553.672.303.07
Operating Income(1.58)(1.93)(2.06)(1.51)(1.79)(2.00)(1.81)(2.90)(2.62)(2.49)(3.57)(3.18)(2.48)(2.85)(3.41)(3.79)(2.53)(3.67)(2.26)(2.44)
Interest Expense----------------------------------------
Net Income(1.55)(1.88)(2.02)(1.49)(1.76)(6.25)(1.75)(2.81)(2.57)(2.43)(3.47)(3.03)(2.47)(2.85)(3.28)(3.78)(6.64)(2.01)(2.26)(2.44)
Basic EPS(4.02)(17.85)(2.45)(18.70)(4.25)(39.55)(0.65)(1.00)(1.70)(4.55)(6.85)(6.10)(0.55)(0.60)(0.70)----(0.90)----
Diluted EPS(4.02)(17.85)(2.45)(18.70)(4.25)(39.55)(0.65)(1.00)(1.70)(4.55)(6.85)(6.10)(0.55)(0.60)(0.70)----(0.90)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021
Operating Cash Flow(1.90)(1.75)(1.87)(1.66)(1.71)(1.67)(2.01)(2.21)(1.75)(2.57)(2.38)(5.19)(2.95)(7.56)(2.48)(3.10)(6.67)(5.61)(2.24)(2.20)
Capital Expenditures0.01--0.00-----0.000.000.000.000.000.010.240.010.930.230.210.140.780.010.03
Free Cash Flow*(1.91)--(1.88)----(1.67)(2.01)(2.21)(1.75)(2.57)(2.39)(5.42)(2.96)(8.49)(2.71)(3.31)(6.80)(6.39)(2.24)(2.23)
Investing Cash Flow(0.01)-0.00-0.00----0.00-0.000.000.00-0.00(0.01)(0.24)(0.01)(0.93)(0.23)(0.21)(0.14)(0.78)(0.01)(0.03)
Financing Cash Flow1.82(0.20)2.983.74(0.01)2.36(0.01)-0.005.380.040.181.07-0.008.921.08(0.01)8.468.92(0.03)(0.07)
← Scroll for more columns →

* Derived from reported values